Microbia Selects Spotfire DecisionSite To Speed Drug Discovery Decision Making.Business/Technology Editors and Medical Writers SOMERVILLE, Mass.--(BUSINESS WIRE)--April 15, 2002 Microbia integrates Spotfire's DecisionSite for Lead Discovery(TM) with chemical and biological information to create powerful analytic applications Analytic Applications are a type of business application software, used to measure and improve the performance of business operations. More specifically, Analytic Applications are a type of Business Intelligence solution. Spotfire(R) Inc., a leading provider of analytic applications, today announced that Microbia Inc., a privately held biotechnology company developing novel anti-infective drugs, has chosen Spotfire DecisionSite for Lead Discovery(TM) software. DecisionSite puts analytic capabilities directly into the hands of Microbia's scientists, enabling them to quickly filter through large amounts of data, accelerating analysis in several critical areas of its drug discovery infrastructure. Microbia is developing novel anti-bacterials - Anti-Biofilm(TM) therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. - that target biofilms, complex communities of bacterial cells that allow them to survive various environmental stresses such as antibiotics Antibiotics Definition Antibiotics may be informally defined as the subgroup of anti-infectives that are derived from bacterial sources and are used to treat bacterial infections. . Microbia is also developing a new class of antifungal drugs An antifungal drug is medication used to treat fungal infections such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others. Such drugs are usually obtained by a doctor's prescription or purchased over-the-counter. - Anti-Invasins(TM) - that prevent fungal fungal /fun·gal/ (fun´g'l) fungous; pertaining to fungi. fun·gal or fun·gous adj. 1. Of, relating to, resembling, or characteristic of a fungus. 2. cells from invading in·vade v. in·vad·ed, in·vad·ing, in·vades v.tr. 1. To enter by force in order to conquer or pillage. 2. human tissues. The company uses DecisionSite to access, analyze and derive insight into chemical compound screening data. DecisionSite removes the technology barriers between the scientists and their data, giving them hands-on access and control of the data so they can quickly test out their theories to find the most promising compounds. "Spotfire's DecisionSite is an invaluable part of our drug discovery efforts," said Kevin Durfee, Microbia's director of information technology. "Instead of assigning analysts to create data presentations that help scientists make decisions, the scientists can do it themselves with DecisionSite. It's the best product we've seen that handles complex analysis of both biological and chemical data, but is still easy to use." Microbia integrated DecisionSite with its customized Oracle-based application, called SCOPE, which stores biological screening data, and with MDL MDL - (Originally "Muddle"). C. Reeve, Carl Hewitt and Gerald Sussman, Dynamic Modeling Group, MIT ca. 1971. Intended as a successor to Lisp, and a possible base for Planner-70. Basically LISP 1.5 with data types and arrays. Information Systems' ISIS Host, which stores compounds' chemical properties. This combination of technologies makes DecisionSite even more powerful, Durfee said. "We're building an advanced drug discovery platform around our SCOPE system. Spotfire is a critical piece of that system and provides a strategic advantage for our company." "Pharmaceutical start-ups are in a constant battle with time and are always looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. ways to speed up their processes," said David Hadfield, vice president of worldwide sales for Spotfire. "DecisionSite gives these companies powerful interactive analytic capabilities that replace the traditional time-consuming approach to complex data analysis." About Microbia Microbia (www.microbia.com) is a privately held biotechnology company harnessing microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. circuitry to develop safer, more effective drugs and biomanufacturing products. The Company's priorities are the development of anti-biofilm therapeutics, antifungal drugs, and a portfolio of technologies to enhance the production of microbially produced drugs and fine chemicals. Microbia is located in Cambridge, MA. About Spotfire Spotfire(R), Inc. provides analytic applications and services for product lifecycle Product lifecycle or product life cycle is the course of a product's sales and profits over time. The five stages of each product lifecycle are product development, introduction, growth, maturity and decline. decision-making. Spotfire accelerates decision-making by empowering end-users and their enterprises with the insight and the information required to make great product lifecycle decisions. Spotfire customers quickly save costs and improve decisions on how products are developed, manufactured, distributed, marketed and sold. More than 400 global 2000 customers and over 16,000 users work with Spotfire products worldwide. The company maintains U.S. headquarters in Somerville, Mass., and European headquarters in Goteborg, Sweden. Additional information can be found at http://www.spotfire.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion